Compare Cronos Group Inc (CRON) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Shell PLC — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Shell PLC trades at $100.2 (market cap $284.34B). The key difference: Shell PLC is far larger — about 241× Cronos Group Inc's market cap, and Shell PLC pays a 3.12% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Shell PLC for 90 Days on average.
| CRON | SHEL | |
|---|---|---|
Market Cap | $1.18B | $284.34B |
Volume | 968,037 | 9,097,469 |
Sector | Health | Energy |
52-Week High | $3.55 | $100.20 |
52-Week Low | $2.30 | $70.31 |
Typical Hold Time | 22 Days | 90 Days |
Enterprise Value | $387.62M | $326.04B |
Dividend Yield | — | 3.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Shell (SHEL) trades at $96.85, down 0.79% on the day, with strong technical momentum indicated by bullish moving averages and a 52-week high near $99.16. The company shows solid fundamentals with a P/E of 10.71 and ROE of 14.35%, while recent earnings beat expectations in Q1 and Q2 2026. Key developments include the approval of LNG Canada Phase 2 expansion, doubling export capacity, and strategic portfolio optimization through asset divestments.
Outlook remains positive with analyst consensus at Buy (61.5%) and a $102.53 price target, though risks include volatile energy prices and execution challenges in major projects. The stock offers value through attractive valuation metrics and growth in LNG operations, supported by strong cash flow generation despite recent revenue declines from 2022 peaks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
